Trade Summary

3 days ago, Forbion Growth Opportunities Fund III Cooperatief U.A., serving as 10% owner Owner at Braveheart Bio, Inc. (BRVE), purchased 3,600,000 shares at $18.00 per share, for a total transaction value of $64,800,000.00. Following this transaction, Forbion Growth Opportunities Fund III Cooperatief U.A. now holds 10,185,478 shares of BRVE.

This purchase represents a 54.67% increase in Forbion Growth Opportunities Fund III Cooperatief U.A.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 7, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 5:25 PM ET, meaning the disclosure happened on the same day as the trade.

Braveheart Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.